.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

NEMBUTAL Drug Profile

« Back to Dashboard
Nembutal is a drug marketed by Oak Pharms and is included in six NDAs.

The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentobarbital sodium profile page.

Summary for Tradename: NEMBUTAL

Patents:0
Applicants:1
NDAs:6

Clinical Trials for: NEMBUTAL

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms
NEMBUTAL
pentobarbital
ELIXIR;ORAL083244-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Oak Pharms
NEMBUTAL SODIUM
pentobarbital sodium
INJECTABLE;INJECTION083246-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Oak Pharms
NEMBUTAL
pentobarbital sodium
SUPPOSITORY;RECTAL083247-003Jan 25, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc